(Q73008373)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Prediction of response to primary chemotherapy for operable breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

E Orvieto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

F Nolé

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

L Orlando

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

I Minchella

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G Viale

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G Peruzzotti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

C Robertson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

C Noberasco

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

V Galimberti

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

V Sacchini

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

P Veronesi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

S Zurrida

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

R Orecchia

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A Goldhirsch

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 April 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

574-579

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

Primary chemotherapy in surgically resectable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

Concepts for systemic treatment of micrometastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

Clinical and pathological response to primary chemotherapy in operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

Mutant p53 protein associated with chemosensitivity in breast cancer specimens.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900005-2

7 January 2021

10.1016/S0959-8049(99)00005-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10492630%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference